R&D Systems代理6576-B7-050 Recombinant Human B7-H4 His Tagged Protein, CF (50 UG)

2025-06-28

货号:6576-B7-050

品牌:R&D Systems

规格:50ug

目录价:¥4630.00

市场价格:¥3704.00

会员价格:¥3704.00

  • 到货时间:3~4周

    金山科研平台,产品价格货期咨询微信:jinshanbio Source:Mouse myeloma cell line, NS0-derived, Phe29-Ala258, with a C-terminal 10-His tag Accession #:NP_078902 N-terminal Sequence Analysis:Phe29 Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Endotoxin Level: Predicted Molecular Mass:26.7 kDa SDS-PAGE:45-60 kDa, reducing conditions Activity:Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes.The ED50 for this effect is typically 0.5 -2.5 µg/mL. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: B7-H4 Long Name: B7 Homolog 4 Aliases: B7S1; B7x; Vtcn1 Entrez Gene IDs: 79679 (Human); 242122 (Mouse) Background: B7-H4

    B7-H4, also known as B7x and B7S1, is a member of the B7 family of immune costimulatory proteins. Mature B7-H4 is a 50 kDa - 80 kDa glycosylated molecule with a 28 kDa protein core. Partial sensitivity to cleavage by PI-PLC suggests a possible GPI linkage of mouse B7-H4 to the cell membrane. The 230 aa extracellular region of B7-H4 contains one Ig-like V-set domain and one Ig-like C2-set domain which is followed by a hydrophobic C-terminal region. Within the ECD, mouse B7-H4 shares 90% and 99% aa sequence identity with human and rat B7-H4, respectively. It shares 21% - 29% aa sequence identity with B7-1, B7-2, B7-H1, B7-H2, B7-H3, and PD-L2.

    B7-H4 expression is induced on mitogen- or LPS-activated B cells, T cells, dendritic cells, monocytes, and macrophages and blocked by GM-CSF or IL-4. It is also expressed on various normal epithelia and upregulated in several carcinomas and renal tubule epithelial cell lesions. B7-H4 is expressed on the surface of macrophages but intracellularly in ovarian and breast cancer cells. It is found in the serum and ascites fluid of cancer patients. B7-H4 binds an unidentified ligand on activated T cells which is distinct from BTLA, CD28, CTLA4, ICOS, and PD-1. Exposure to B7-H4 inhibits antigen-dependent induction of T cell proliferation and activation. Alternatively, B7-H4 expressing renal tubular epithelial cells promote T cell activation. Regulatory T cells, IL-6, and IL-10 induce B7-H4 expression on antigen presenting cells which fosters tumor growth by dampening the anti-tumor immune response. B7-H4 also promotes the malignant transformation of epithelial cells by protecting them from apoptosis. Despite evidence for the involvement of B7-H4 in immune regulation, mice deficient in its expression do not show significant immune deficiencies, suggesting compensation by other molecules in vivo.

    © 金山科研平台是专业的授权总代理区域代理经销平台。
    © 如需询价,请加客服QQ:1749072012 、客服微信:jinshanbio,或发送邮件到1749072012@qq.com
    © 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务,数据资源基于CC协议。
    © 本文地址:https://www.16ao.com/thread-137744.htm
    © R&D Systems代理6576-B7-050 Recombinant Human B7-H4 His Tagged Protein, CF (50 UG),产品报价联系微信jinshanbio
  • 产品询价需求提交
    产品询价请加微信:jinshanbio
    返回